Navigation Links
DrugRisk Adds Study Showing Pradaxa May Increase Viral Infection Risk
Date:4/3/2013

Denver, CO (PRWEB) April 03, 2013

The prescription drug safety advocates at DrugRisk.com are alerting patients of new information on the site for those taking the blood thinner Pradaxa. A new study from The University of North Carolina suggests the atrial fibrillation drug may increase the chances of contracting some viral infections****.

DrugRisk was created to improve the safety of those taking prescription drugs by sharing the latest warnings, recalls, studies and legal news. Patients can see if others are experiencing similar side effects and decide if they need legal advice.

Experts have disagreed over whether Pradaxa, launched in 2010 to prevent strokes in patients with atrial fibrillation, causes higher risks of internal bleeding. The FDA recently advised that Pradaxa is no more dangerous than traditional blood thinner warfarin*.

The Institute for Safe Medication Practices, however, ranked blood thinners like Pradaxa among the most dangerous drugs, and warned that patients suffering Pradaxa bleeding are almost 5 times as likely to die than those with bleeding from warfarin**. Researchers with the University of Illinois at Chicago also recently warned that the data used by the FDA may be flawed, and the risk for bleeding from Pradaxa may be higher than previously thought***.

Now, DrugRisk has learned of a new study by researchers at the University of North Carolina, which suggests the blood-thinning properties of Pradaxa may make patients more susceptible to certain viral infections****. By reducing the innate properties of thrombosis, users may become more prone to flu and myocarditis****.

Already, more than 260 patients have filed a Pradaxa lawsuit over allegations of internal bleeding, which have been consolidated to a special federal court in Illinois. The case is formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

Anyone affected by alleged Pradaxa internal bleeding after taking the drug is encouraged to speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugRisk only recommends lawyers who have already handled Pradaxa lawsuits.

For more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*http://www.fda.gov/Drugs/DrugSafety/ucm326580.htm
**Instutute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
***http://www.dailyrx.com/dabigatran-prevent-stroke-and-blood-clots-may-cause-excess-bleeding-reports-are-conflicting
****http://www.sciencedaily.com/releases/2013/04/130401132058.htm

Read the full story at http://www.prweb.com/releases/pradaxa-internal-bleeding/lawsuit-recall/prweb10594448.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
2. DrugRisk Announces Alternative to Mirena IUD May Be Available Soon
3. DrugRisk Announces Updated Information on Mirena Lawsuits
4. DrugRisk Adds Latest Health Warnings and Lawsuit Updates for Yaz
5. DrugRisk Announces New Pradaxa Health Warning From Australia
6. DrugRisk Update: NuvaRing Lawsuit Trials to Begin This Year
7. DrugRisk Update: Court Allows Charges of Prior Fraud Into Pradaxa Lawsuit
8. DrugRisk Pradaxa Lawsuit Update: Court Denys Boehringer’s Protective Order Request
9. DrugRisk Pradaxa Update: Litigation Grows As New Study Adds to Risks
10. DrugRisk Update: Bayer Discloses $500 Million Remaining for Yaz Lawsuits
11. DrugRisk Update: Evidence Submitted in Actos Lawsuit Suggests Drug Maker Knew of Cancer Risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... May 24, 2016 , ... Regenerative Medicine is being transformed by ongoing ... therapy technology, protocols and patient results as have been achieved with Okyanos Cell ... accessible standard of care for patients worldwide. , As the Medical Advisory Chairman at ...
(Date:5/24/2016)... New York, NY (PRWEB) , ... May 24, ... ... of rehabilitative treatment for physical disease or injury that focuses on repairing the ... surgery. , With an emphasis on functional restoration, NYDNRehab began providing treatments ...
(Date:5/24/2016)... ... ... A newly released report reveals that improving life outcomes for boys and men ... interactions and online. In “Heard, Not Judged – Insights into the Talents, Realities and ... digital devices can be an effective tool to help boys and men of color ...
(Date:5/24/2016)... ... May 24, 2016 , ... The ... clinical practice of radiosurgery, is recognizing five medical residents and students for their ... body radiotherapy (SBRT). The awards will be presented at the 2016 SRS/SBRT Scientific ...
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... Tuesday, May ... , The Yoga practice enhanced with Young Living Essential Oils, taught by Patti Dolan, ... at the Lake Orion location. Yoga Flow is 6:30pm - 7:15pm followed by a ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... , May 23, 2016 ... for the treatment of cancer and orphan genetic diseases, ... up to $4.4 million from the Israel Innovation Authority ... Israeli Ministry of Economy and Industry. The mission of ... entrepreneurship in various industries, including science and technology, while ...
(Date:5/23/2016)... May 23, 2016   Purdue Pharma L.P. ... an agreement with Egalet Corporation and Acura Pharmaceuticals, ... part of the agreement the companies will exchange ... all three companies to develop and sell several ... "This agreement reflects the commitment of Purdue Pharma ...
(Date:5/20/2016)... , May 20, 2016 ... 2016 to Medical Devices of its online business ... survey on the current state of the Titrator ... the industry like definitions, classifications, Specifications, applications and ... manufacturing process like Raw Material Suppliers, Equipment Suppliers, ...
Breaking Medicine Technology: